On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
April 21st 2024
Data presented at ACP 2024 shows non-White patients may be particularly subjected to more risk of discrimination in their care when ED boarding extends past 24 hours.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Gene Therapy for Hemophilia B—The Next Step Forward in Disease Management
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies
View More
BURST Expert Illustrations & Commentaries™: A Closer Look at the Role of Complement Inhibitors in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
View More
Medical Crossfire®: How Have HER2-Low Expressing Breast Cancers and Novel Advances in the Field Redefined Care As We Knew It?
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
Community Practice Connections™: 20th Annual Winter Lung Conference
View More
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer
View More
Show Me Your Care Plan: Nursing Considerations for Managing Breast Cancer Patients
View More
Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care
View More
Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
Community Practice Connections™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Clinical Case Vignette Series™: 40th Annual Miami Breast Cancer Conference®
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities
View More
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
View More
Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Expert Illustrations & Commentaries™: Exploring the Mechanistic Rationale for Targeting FGFR2 and Pan-FGFR in CCA
View More
Oncology Town Hall™: Primary Investigators Present Key Abstracts in Multiple Myeloma from the Summer Meetings
View More
What Should I Prescribe for This Man's Depression?
January 1st 2014Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.
New Management and Treatment Guidelines Published for Hepatitis C Virus
The European Association for the Study of the Liver published their updated Clinical Practice Guidelines for the management of the hepatitis C virus, which includes updates regarding people who inject recreational drugs.
Pediatrics Group Cautions Against Raw Milk Consumption by Children, Pregnant Women
The American Academy of Pediatrics (AAP) has called for the sale of raw milk to be banned in the United States, as it warned that women, children, and infants should only consume pasteurized milk and milk products.
FDA to Consider Tighter Standards for Generic Epilepsy Drugs
Studies on drug pharmacokinetics in epilepsy patients are being conducted to help the US Food and Drug Administration (FDA) consider whether it needs to tighten bioequivalence rules for generic anti-epilepsy drugs (AEDs) and other medications that have narrow therapeutic windows.
Brintellix Tackles Cognitive Dysfunction Related to Major Depression
In addition to treating episodes of major depression, Brintellix (vortioxentine) has demonstrated superiority to placebo on measures of cognitive function in adult patients with major depressive disorder (MDD).
Increasing NMDA Glutamate Receptor Instead of Blocking It Produces Antidepressant-Like Effects
Results from animal models of depression and a human clinical trial show that enhancing, instead of blocking, the NMDA glutamate receptor can cause antidepressant-like effects.
Within a year of their diagnosis, nearly half of all first-line drug-treated MDD patients were also treated with a second-line therapy, a new study finds. Cymbalta leads the market in second-line therapy, used individually or as a combination, and Abilify is the leading atypical antipsychotic.
Experimental Compound May Reduce Joint Inflammation in Rheumatoid Arthritis
Researchers using mice models have shown that the compound SR2211, which targets a nuclear receptor that is a key regulator of TH17 cells, significantly reduces joint inflammation and erosion.
Thalidomide Extends Remission Duration in Children with Crohn's Disease
A new randomized, double-blind, placebo-controlled study of 56 children with Crohn's disease suggests pediatric patients treated with thalidomide have better rates of remission and response than those given placebo.
Mediterranean Diet as a Primary Prevention of Cardiovascular Disease
December 1st 2013Compared to a low-fat diet, adherence to a Mediterranean diet has significant benefit in the primary prevention of cardiovascular disease among patients aged 55-80 years old at high baseline cardiovascular risk without cardiovascular disease.
FDA Reduces Restrictions on Diabetes Medication Rosiglitazone
November 26th 2013Following an extended review of safety data that showed no elevated risk of heart attack or death in patients taking rosiglitazone, the FDA announced it is lifting certain restrictions on the prescribing and dispensing of the drug.